Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Impulsar los recursos para el cuidado de la traqueostomía en el hogar (BREATHE)

25 de septiembre de 2026 actualizado por: Karen Sepucha, Massachusetts General Hospital

Impulsar los recursos y el empoderamiento de los cuidadores para la atención de la traqueostomía en el hogar: un ensayo aleatorizado pragmático

The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main questions it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will be randomly assigned to receive Trach Me Home (gold standard discharge program) or Trach Me Home with additional components. Caregiver participants will complete three surveys over the course of 6 months. Researchers will see if caregivers in the Trach Me Home with additional components report lower caregiver burden at 4 weeks post discharge (primary outcome) and fewer hospital readmissions at 6 months than those in Trach Me Home arm.

Descripción general del estudio

Estado

Inscripción por invitación

Descripción detallada

The study is focused on a rare and medically complex population of children with tracheostomies. The study is a Type I hybrid effectiveness-implementation study using a pragmatic randomized trial at six participating sites. The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main question[s] it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will randomly assigned to the Comparator arm (gold standard discharge program) or to the Intervention arm (gold standard program with other components). Caregiver participants will complete three surveys over the course of 6 months. The investigators will test two main hypotheses: the Intervention arm will have (1) significantly lower caregiver burden at 4 weeks post discharge (primary outcome) and (2) significantly lower readmissions or emergency room visits at 6 months post discharge than the Comparator arm.

The investigators will also survey pediatricians of participating patients at 6 months post discharge and examine whether intervention arm pediatricians have higher satisfaction with discharge communication than those in comparator arm.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

480

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • California
      • La Jolla, California, Estados Unidos, 92093
        • University of San Diego Rady Children's Hospital
    • Maryland
      • Silver Spring, Maryland, Estados Unidos, 20910
        • Children's National Medical Center, Children's Research Institute
    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02114
        • Massachusetts General Hospital
    • Minnesota
      • Minneapolis, Minnesota, Estados Unidos, 55404
        • Children's Hospitals and Clinics of Minnesota
    • Ohio
      • Cincinnati, Ohio, Estados Unidos, 45229
        • Cincinnati Children's Hospital Medical Center
    • Pennsylvania
      • Philadelphia, Pennsylvania, Estados Unidos, 19146
        • Children's Hospital of Philadelphia

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Lead or primary adult caregiver (18 or older) of infants or children (0-17 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator

Exclusion Criteria:

  • Patients transferred to other hospital or facility (and/or not discharged to home during study period)
  • Primary caregiver unable to read or write in English, Spanish, Mandarin, or Arabic
  • Not residing in the U.S. for at least 12 months after discharge

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Investigación de servicios de salud
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Active Comparator Caregivers

TrachMeHome program delivered in the hospital including education, skills training and case management for caregivers

The Trach Me Home discharge program includes caregiver education, skills training and case management.

Experimental: Intervention Caregivers

Trach Me Home and Trach Plus with additional education, outpatient care team communication and social support for caregivers.

The Trach Me Home discharge program includes caregiver education, skills training and case management.

The Trach Plus program includes education, social support, and outreach to outpatient care team.

Comparador activo: Active Comparator Physicians

Primary care physicians' of the enrolled participant's child receiving discharge communication

The Trach Me Home discharge program includes caregiver education, skills training and case management.

Experimental: Intervention Physicians

Primary care physicians' of the enrolled participant's child receiving outpatient care team communication prior to discharge

The Trach Me Home discharge program includes caregiver education, skills training and case management.

The Trach Plus program includes education, social support, and outreach to outpatient care team.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Caregiver Burden
Periodo de tiempo: 4 weeks post-discharge

Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

4 weeks post-discharge

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Medical Complications Associated with Tracheostomy
Periodo de tiempo: 6 months post-discharge

4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

6 months post-discharge
6-month Readmission Rate
Periodo de tiempo: 6 months post-discharge

Percentage with one or more emergency room visits or hospital readmissions as documented in the electronic health record within 6 months of discharge.

6 months post-discharge
Frequency of pediatrician communication
Periodo de tiempo: 6 months post-discharge

Percentage of pediatrician-specific communication with inpatient team prior to and/or shortly after discharge documented in electronic medical record or by pediatrician report.

6 months post-discharge
Primary care pediatrician satisfaction
Periodo de tiempo: 6 months post-discharge

Clinician reported satisfaction with discharge communication scored from 0-100, higher scores indicate higher satisfaction with discharge communication.

6 months post-discharge
Medical Complications Associated with Tracheostomy
Periodo de tiempo: 4 weeks post-discharge

4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

4 weeks post-discharge
Caregiver Burden
Periodo de tiempo: 6 months post-discharge

Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

6 months post-discharge

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of readmissions
Periodo de tiempo: 6 months post discharge

The total number of electronic health record documented emergency room visits and hospital admissions will be collected, with higher numbers being worse (indicating more readmissions).

6 months post discharge

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Karen Sepucha, PhD, Massachusetts General Hospital
  • Investigador principal: Christopher Hartnick, MD, Massachusetts Eye and Ear Infirmary / Massachusetts General Hospital

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

16 de mayo de 2024

Finalización primaria (Estimado)

1 de diciembre de 2026

Finalización del estudio (Estimado)

1 de octubre de 2027

Fechas de registro del estudio

Enviado por primera vez

21 de febrero de 2024

Primero enviado que cumplió con los criterios de control de calidad

21 de febrero de 2024

Publicado por primera vez (Actual)

28 de febrero de 2024

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

30 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

25 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2023P001695
  • IHS-2022C1-26100 (Otro número de subvención/financiamiento: Patient Centered Outcomes Research Institute (PCORI))

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

To promote research replicability, transparency and future use of the data, de-identified data sets will be created and will be available, by request, to outside researchers.

The Data Package (comprised of the de-identified Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan, and analytic code from the project) will be deposited in the Patient-Centered Outcomes Research Institute's Data Repository at the ICPSR. Participant information sheets for the study will indicate that de-identified information will be deposited in an open access service to promote use of the data by other researchers. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set. No data will be provided from qualitative transcripts as this may lead to identifying information about participants. However, codes abstracted from qualitative transcripts may be made available.

Marco de tiempo para compartir IPD

After study results have been published, about 1 year after the end of the funded grant period, the study materials and de-identified data will be placed on an open access service such as ICPSR where they will be available indefinitely.

Criterios de acceso compartido de IPD

Researchers may access the data through the PCORI-designated repository (ICPSR's website) once it is made available.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir